Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Revenue

Harvard Bioscience had revenue of $21.97M in the quarter ending September 30, 2024, a decrease of -13.38%. This brings the company's revenue in the last twelve months to $97.73M, down -13.15% year-over-year. In the year 2023, Harvard Bioscience had annual revenue of $112.25M, down -0.96%.

• Revenue (ttm): $97.73M
• Revenue Growth: -13.15%
• P/S Ratio: 0.96
• Revenue / Employee: $234,933
• Employees: 416
• Market Cap: 94.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	112.25M	-1.09M	-0.96%
Dec 31, 2022	113.34M	-5.57M	-4.68%
Dec 31, 2021	118.90M	16.80M	16.46%
Dec 31, 2020	102.10M	-14.08M	-12.12%
Dec 31, 2019	116.18M	-4.60M	-3.81%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.